Cargando…

Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response

OBJECTIVE: Cancer cachexia is often present in patients with advanced malignant tumors, and the subsequent body weight reduction results in poor quality of life. However, there has been no progress in developing effective clinical therapeutic strategies for skeletal muscle wasting in cancer cachexia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Dunwei, Wang, Chaoyi, Wang, Qiang, Qiao, Zhongpeng, Tang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503639/ https://www.ncbi.nlm.nih.gov/pubmed/28489606 http://dx.doi.org/10.18632/oncotarget.17387

Ejemplares similares

Inflammation and Skeletal Muscle Wasting During Cachexia
por: Webster, Justine M., et al.
Publicado: (2020)

STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
por: Bonetto, Andrea, et al.
Publicado: (2011)

Exploring the Therapeutic Potential of Ethyl 3-Hydroxybutyrate in Alleviating Skeletal Muscle Wasting in Cancer Cachexia
por: Zhou, Yu, et al.
Publicado: (2023)

The JAK/STAT Pathway in Skeletal Muscle Pathophysiology
por: Moresi, Viviana, et al.
Publicado: (2019)

Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
por: Rausch, Valentina, et al.
Publicado: (2021)

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
por: Lenk, Karsten, et al.
Publicado: (2010)

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
por: Bowen, T Scott, et al.
Publicado: (2015)

MicroRNAs in Skeletal Muscle and Hints on Their Potential Role in Muscle Wasting During Cancer Cachexia
por: Marceca, Gioacchino P., et al.
Publicado: (2020)

Skeletal muscle wasting after a severe burn is a consequence of cachexia and sarcopenia
por: Song, Juquan, et al.
Publicado: (2021)

Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1
por: Tao, Weili, et al.
Publicado: (2023)

Cardiac muscle wasting in individuals with cancer cachexia
por: Barkhudaryan, Anush, et al.
Publicado: (2017)

Mathematical Model of Muscle Wasting in Cancer Cachexia
por: Farhang-Sardroodi, Suzan, et al.
Publicado: (2020)

Amelioration of muscle wasting by gintonin in cancer cachexia
por: Wijaya, Yoseph Toni, et al.
Publicado: (2021)

Peptide‐2 from mouse myostatin precursor protein alleviates muscle wasting in cancer‐associated cachexia
por: Ojima, Chiharu, et al.
Publicado: (2020)

Research on cachexia, sarcopenia and skeletal muscle in cardiology
por: Coats, Andrew J. S.
Publicado: (2012)

Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia
por: Miao, Chunxiao, et al.
Publicado: (2021)

Bone Marrow Homeostasis Is Impaired via JAK/STAT and Glucocorticoid Signaling in Cancer Cachexia Model
por: Yu, Jinyeong, et al.
Publicado: (2021)

Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting
por: Zanders, Lukas, et al.
Publicado: (2021)

2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle
por: Wei, Lulu, et al.
Publicado: (2022)

Phosphorylation of Dynamin-Related Protein 1 (DRP1) Regulates Mitochondrial Dynamics and Skeletal Muscle Wasting in Cancer Cachexia
por: Mao, Xiangyu, et al.
Publicado: (2021)

FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness
por: Neyroud, Daria, et al.
Publicado: (2021)

Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer
por: Koh, Jin Sung, et al.
Publicado: (2018)

The Skeletal Muscle as an Active Player Against Cancer Cachexia
por: Penna, Fabio, et al.
Publicado: (2019)

Environmentally Benign and Facile Process for the Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate
por: Awasthi, Arun Kumar, et al.
Publicado: (2017)

Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia
por: Aquila, Giorgio, et al.
Publicado: (2020)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2019)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2020)

Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy
por: Huang, Ziwei, et al.
Publicado: (2020)

Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass
por: Sakuma, Kunihiro, et al.
Publicado: (2012)

Emerging Mechanisms of Skeletal Muscle Homeostasis and Cachexia: The SUMO Perspective
por: Khan, Bushra, et al.
Publicado: (2023)

Mitophagy-mediated inflammation and oxidative stress contribute to muscle wasting in cancer cachexia
por: Zhang, Zhige, et al.
Publicado: (2023)

Pharmacokinetics of Pantoprazole and Pantoprazole Sulfone in Goats After Intravenous Administration: A Preliminary Report
por: Smith, Joe S., et al.
Publicado: (2021)

The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia
por: Cheung, Wai W., et al.
Publicado: (2021)

The role of insulin resistance in the development of muscle wasting during cancer cachexia
por: Honors, Mary A., et al.
Publicado: (2011)

Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia
por: Ábrigo, Johanna, et al.
Publicado: (2018)

Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
por: Chiappalupi, Sara, et al.
Publicado: (2020)

Prevention of chemotherapy‐induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle
por: Hulmi, Juha J., et al.
Publicado: (2017)

Preclinical characterization of the JAK/STAT inhibitor SGI-1252 on skeletal muscle function, morphology, and satellite cell content
por: Sorensen, Jacob R., et al.
Publicado: (2018)

Erratum to inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy
Publicado: (2021)

β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy
por: Kim, Yerin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f69fmlf078bfjjiq1g560995e3